Avanafil - a novel phosphodiesterase inhibitor for treating erestile dyscunction in clinical practice. How is it different from the established molecules?

Abstract

Phosphodiesterase-5 inhibitors are drugs of choice for erectile dysfunction treatment. Now, there is new one molecule on the marketavanafil.

What is the difference between avanafil and other PDE-5 inhibitors?

Keywords

• avanafil
• erectile dysfunction
• pharmacokinetics, adverse effects